hypopigmented mycosis fungoides: clinical, histological, and immunohistochemical remission induced by narrow-band ultraviolet b
Clicks: 130
ID: 159087
2017
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
130 views
31 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #89 of 170 articles by views in heterocycles
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 170 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Mycosis fungoides (MF) is the most common type of primary cutaneous lymphomas. Several clinical variants of MF have been described. Purely, hypopigmented variant of MF (HMF) is rare. Phototherapy, especially photochemotherapy (Psoralen and ultraviolet), is the most widely used method and is recommended as the first-line treatment for HMF. However, there are no standard guidelines for phototherapy as the disease is uncommon. We, hereby, report a 30-year-old woman with HMF in whom clinical, histopathological, and immunohistochemical remission was achieved following narrow-band ultraviolet B therapy.
| Reference Key |
bisherwal2017indianhypopigmented
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Kavita Bisherwal;Archana Singal;Deepika Pandhi;Sonal Sharma |
| Journal | heterocycles |
| Year | 2017 |
| DOI |
10.4103/ijd.IJD_365_16
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.